AKNAD1

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA030270

Antibody HPA030271

Antibody HPA030272

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Prostate cancers displayed strong cytoplasmic and membranous immunoreactivity. A few cases of hepatocellular carcinomas showed weak to moderate staining. Remaining malignant cells were negative.Malignant tissues exhibited weak to moderate cytoplasmic immunoreactivity. A few cases of colorectal cancers showed strong staining. Malignant gliomas and lymphomas were generally negative.Among tumors, a few cases of colorectal, thyroid, endometrial, breast, renal and liver cancers showed moderate cytoplasmic immunoreactivity. Remaining malignant tissues were either negative or weakly stained.

Literature conformity

No avaliable characterization dataNo avaliable characterization dataNo avaliable characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected